Objective To investigate the expression levels of serum microRNA-155 (miR-155) and chemokine 8 (CXCL8) in children with cough variant asthma (CVA), and to discuss the clinical significance of these indicators. Methods A total of 86 CVA patients treated in Daxing Maternal and Child Health Hospital of Beijing from March 2017 to February 2019 were selected as study objects (experiment group), and 90 healthy children who underwent physical examination at the same time were selected as the control group.The general clinical data were collected, sputum eosinophil (EOS) count, exhaled nitric oxide (FeNO) and pulmonary function indexes including forced expiratory volume in one second (FEV1), peak expiratory flow rate (PEF) and forced expiratory volume in one second/forced vital capacity (FEV1/FVC) were measured.Pearson method was used to analyze the correlation between miR-155, CXCL8 levels and EOS, FeNO, lung function.In addition, receiver operating characteristic curve (ROC) was used to analyze the predictive value of serum miR-155 and CXCL8 levels for CVA. Results Compared with the control group, the levels of EOS, FeNO, miR-155 and CXCL8 in the experiment group were significantly higher(t=11.606, 27.562, 19.721, 10.754, P<0.05), while the levels of FEV1, PEF and FEV1/FVC were significantly lower (t=17.471, 10.975, 33.605, P<0.05).Pearson analysis showed that miR-155 and CXCL8 were positively correlated with EOS and FeNO (P<0.05), and negatively correlated with FEV1, PEF and FEV1/FVC (P<0.05).The area under the curve of miR-155 and CXCL8 was 0.821 (95% CI:0.675-0.967) and 0.851 (95% CI:0.741-0.961), respectively.The area under the curve of combined detection in predicting CVA was 0.935 (95% CI:0.914-0.975). Conclusion The levels of serum miR-155 and CXCL8 in children with CVA are increasing, which has certain predictive value for CVA, and may be used as potential serological markers for the diagnosis of CVA.
Key words
cough variant asthma /
microRNA-155 /
chemokine 8
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 王春燕, 隆红艳.儿童CVA的中医研究进展[J].中医儿科杂志, 2019, 15(5):91-94.
[2] 焦鹏洋, 韩雪.儿童咳嗽变异性哮喘的中西医治疗研究进展[J].中医临床研究, 2018, 10(18):29-31.
[3] Specjalski K, Niedoszytko M.MicroRNAs:future biomarkers and targets of therapy in asthma[J].Curr Opin Pulm Med, 2020, 26(3):285-292.
[4] 代香兰, 兀威, 冯梅.MicroRNA-155在支气管哮喘中的研究进展[J].国际呼吸杂志, 2018, 38(2):118-121.
[5] 赵彦超, 闫洁.乌司他丁对支气管哮喘患者呼出气一氧化氮及血清 IL-8、IL-17水平的影响[J].山东医药, 2016, 56(35):96-97,98.
[6] 干瑶, 范绍辉, 陈艳琳, 等.急性呼吸窘迫综合征小鼠肺组织MIP-2 、IL-8 mRNA表达及支气管肺泡灌洗液中性粒细胞百分比观察[J].山东医药, 2019, 59(3):43-46.
[7] 吴莉菁, 肖国军.孟鲁司特钠片联合布地奈德混悬液治疗CVA患儿的临床研究[J].中国临床药理学杂志, 2016, 32(22):2032-2034,2038.
[8] 古辉,徐小彭,黄国华, 等.慢性阻塞性肺病患者呼出气冷凝液白细胞介素33与气道嗜酸性粒细胞的关系[J].实用医学杂志,2019,35(5):756-759.
[9] 敖敏,郭述良,税莉莉,等.呼出气一氧化氮在咳嗽变异性哮喘诊断中的价值[J].重庆医科大学学报,2019,44(3):322-326.
[10] Malmhäll C, Johansson K, Winkler C, et al.Altered miR-155 expression in allergic asthmatic airways[J].Scand J Immunol, 2017, 85(4):300-307.
[11] Zhou H, Li J, Gao P,et al.miR-155:A novel target in allergic asthma[J].Int J Mol Sci, 2016, 17(10):1773-1781.
[12] 杜春玲, 徐侃, 闵智慧, 等.外周血CD4+记忆T细胞的表型及其与支气管哮喘严重程度的相关性[J].中华医学杂志, 2017, 97(30):2333-2337.
[13] 张梦莹, 李志, 李雪琴, 等.哮喘小鼠脾脏来源CD4~+ T细胞促进体外培养巨噬细胞的M2极化[J].细胞与分子免疫学杂志, 2019, 35(4):289-295.
[14] 王鸿雁, 刘华, 余宏鑫, 等.成人支气管哮喘患者血浆可溶性晚期糖基化终产物受体的表达及其相关性[J].中华结核和呼吸杂志, 2018, 41(1):66-67.
[15] Chen H, Xu X, Cheng S, et al.Small interfering RNA directed against microRNA-155 delivered by a lentiviral vector attenuates asthmatic features in a mouse model of allergic asthma[J].Exp Ther Med, 2017, 14(5):4391-4396.